Univar (UNVR) Expands Pharmaceutical Ingredients In EMEA
Zacks Investment Research | Feb 18, 2020 09:01PM ET
Univar Solutions Inc. (NYSE:UNVR) announced the expansion of its Pharmaceutical Ingredients as a Dedicated Industry Vertical across Europe, the Middle East and Africa. Through the launch, the company continues to invest in its dedicated model.
The new group allows Univar to serve the pharmaceutical ingredients market worldwide with expertise in all major regions. This is supported by a global network of state-of-the-art Solutions Centers geared to meet the increasing demand of customers.
Univar now has a fully worldwide approach for the pharmaceutical ingredients market due to the combination of the new industry vertical team with the already successful organizations operating in North and Latin America.
Per management, the organizational alignment will improve efficiency and increase emphasis on the needs of customers and suppliers of pharmaceutical ingredients. It will also strengthen the company’s commitment to be a responsible provider of solutions.
Notably, Univar launched the business line with its dedicated management, resources and approach to the market to create greater value through specialization.
The company envisions that the expertise provided by a dedicated sales and technical team will strengthen its relationships with suppliers and customers. Notably, the change was made to adapt to the change in market needs and offer a greater depth of focus, eventually bringing value to its suppliers and customers.
Univar’s emphasis on Pharma provides a guarantee to suppliers and customers that it proactively handles short-term regulatory changes and the impacts of the same on its business.
The company’s shares have dipped 5.9% over a year compared with a 29% decline recorded by its Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.